PATH vs VTRS · P/E 19, rev $1.61B vs rev $14.74B
Uipath Inc (PATH) versus Viatris Inc (VTRS) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported VTRS revenue for 2024-12-31 was $14.74B. Net income was -$634.2M. Revenue was down 4.5% from 2023-12-31 to 2024-12-31. VTRS currently screens at market cap $10.83B.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. VTRS currently screens at market cap $10.83B.
Not investment advice. Open the PATH and VTRS stock pages for the full models.
Not investment advice.